Photocure announced the acquisition of Vesica Health and its key asset, AssureMDx, a noninvasive urine-based test for early bladder cancer detection. The deal, valued at about $30.5 million including cash and equity, aims to broaden Photocure's role in bladder cancer care and leverage its commercial infrastructure for growth. This strategic move positions Photocure as a leading uro-oncology platform and could enhance long-term operating leverage. The acquisition includes upfront and milestone payments linked to reimbursement achievements.
The global reactive hot melt adhesives market is projected to grow from $2.02 billion in 2025 to $4.29 billion by 2035, at a CAGR of 7.72%. Growth is driven by regulations limiting solvent-based adhesives, increased use of polyurethane adhesives in a...
SEGG Media Corporation announced that Sports.com Predict will be the Official Prediction Partner for the 2026 UIM E1 World Championship, the first all-electric raceboat series. This partnership aims to enhance fan engagement by integrating real-time ...
In 2026, alternative ETFs have attracted nearly $30 billion in net new assets as investors seek diversification amid high market concentration and positive equity-to-bond correlations. Strategies like the iShares Systematic Alternatives Active ETF (I...
Cinthia Murphy of VettaFi highlighted on Yahoo! Finance that investors are increasingly choosing ETFs such as the ROBO Global Artificial Intelligence ETF (THNQ) to gain diversified exposure across the entire AI value chain. This approach helps mitiga...
Chase Sapphire Preferred updated its hotel credit benefit, doubling it from $50 to $100 while closing a loophole that let cardholders claim the credit without actually staying at a hotel by canceling bookings. Now, the $100 credit requires an actual ...
